MX2009009429A - Analogos de ciclopamina lactama y metodos de uso de los mismos. - Google Patents
Analogos de ciclopamina lactama y metodos de uso de los mismos.Info
- Publication number
- MX2009009429A MX2009009429A MX2009009429A MX2009009429A MX2009009429A MX 2009009429 A MX2009009429 A MX 2009009429A MX 2009009429 A MX2009009429 A MX 2009009429A MX 2009009429 A MX2009009429 A MX 2009009429A MX 2009009429 A MX2009009429 A MX 2009009429A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- lactam analogs
- cyclopamine
- cyclopamine lactam
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención se relaciona a alcaloides esteroidales útiles en el tratamiento de desórdenes relacionados con la ruta hedgehog, particularmente cánceres.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89359107P | 2007-03-07 | 2007-03-07 | |
PCT/US2008/056229 WO2008109829A1 (en) | 2007-03-07 | 2008-03-07 | Cyclopamine lactam analogs and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009009429A true MX2009009429A (es) | 2010-07-05 |
Family
ID=39738826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009429A MX2009009429A (es) | 2007-03-07 | 2008-03-07 | Analogos de ciclopamina lactama y metodos de uso de los mismos. |
Country Status (15)
Country | Link |
---|---|
US (3) | US7964590B2 (es) |
EP (1) | EP2134719B1 (es) |
JP (1) | JP2010520310A (es) |
KR (1) | KR20090117956A (es) |
CN (2) | CN101675054B (es) |
AU (1) | AU2008222655B2 (es) |
BR (1) | BRPI0808444A2 (es) |
CA (1) | CA2679845A1 (es) |
HK (1) | HK1139930A1 (es) |
IL (1) | IL200746A0 (es) |
MX (1) | MX2009009429A (es) |
NZ (1) | NZ579356A (es) |
RU (1) | RU2009137012A (es) |
WO (1) | WO2008109829A1 (es) |
ZA (1) | ZA200906083B (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0514444A (pt) * | 2004-08-27 | 2008-06-10 | Infinity Pharmaceuticals Inc | análogos de ciclopamina e métodos de uso destes |
TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明(cyclopamine)類似物類 |
BRPI0808663A2 (pt) * | 2007-03-07 | 2014-08-26 | Infinity Discovery Inc | Análogos de cicloamina heterocíclicos e métodos de uso dos mesmos |
MX2009009429A (es) | 2007-03-07 | 2010-07-05 | Infinity Discovery Inc | Analogos de ciclopamina lactama y metodos de uso de los mismos. |
US7867492B2 (en) * | 2007-10-12 | 2011-01-11 | The John Hopkins University | Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies |
PE20091180A1 (es) * | 2007-12-27 | 2009-08-26 | Infinity Pharmaceuticals Inc | Tratamientos terapeuticos contra el cancer |
US20100297118A1 (en) * | 2007-12-27 | 2010-11-25 | Macdougall John | Therapeutic Cancer Treatments |
ES2610130T3 (es) | 2007-12-27 | 2017-04-26 | Infinity Pharmaceuticals, Inc. | Métodos para reducción estereoselectiva |
US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
ES2567134T3 (es) | 2009-08-05 | 2016-04-20 | Infinity Pharmaceuticals, Inc. | Transaminación enzimática de análogos de ciclopamina |
US20110065645A1 (en) * | 2009-09-10 | 2011-03-17 | The Regents Of The University Of California | Compositions and Methods for Modulating Neuron Degeneration and Neuron Guidance |
US20110183948A1 (en) * | 2010-01-15 | 2011-07-28 | Infinity Pharmaceuticals, Inc. | Treatment of fibrotic conditions using hedgehog inhibitors |
EP2571357B1 (en) | 2010-05-21 | 2016-07-06 | Infinity Pharmaceuticals, Inc. | Chemical compounds, compositions and methods for kinase modulation |
US9394313B2 (en) | 2010-09-14 | 2016-07-19 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
WO2012064973A2 (en) | 2010-11-10 | 2012-05-18 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
AR084824A1 (es) | 2011-01-10 | 2013-06-26 | Intellikine Inc | Procesos para preparar isoquinolinonas y formas solidas de isoquinolinonas |
AU2012284088B2 (en) | 2011-07-19 | 2015-10-08 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
CN103946226A (zh) | 2011-07-19 | 2014-07-23 | 无限药品股份有限公司 | 杂环化合物及其应用 |
WO2013032591A1 (en) | 2011-08-29 | 2013-03-07 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
WO2013049332A1 (en) | 2011-09-29 | 2013-04-04 | Infinity Pharmaceuticals, Inc. | Inhibitors of monoacylglycerol lipase and methods of their use |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
NZ744567A (en) | 2012-11-01 | 2020-03-27 | Infinity Pharmaceuticals Inc | Treatment of cancers using pi3 kinase isoform modulators |
EP2925363A4 (en) | 2012-11-29 | 2016-11-09 | Strasspharma Llc | METHOD FOR MODULATING FOLLICLE-STIMULATING HORMONACTIVITY |
NZ629037A (en) | 2013-03-15 | 2017-04-28 | Infinity Pharmaceuticals Inc | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
US9192609B2 (en) | 2013-04-17 | 2015-11-24 | Hedgepath Pharmaceuticals, Inc. | Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors |
BR112015029969A2 (pt) | 2013-05-30 | 2017-07-25 | Infinity Pharmaceuticals Inc | tratamento de câncer usando moduladores de isoformas quinase pi3 |
WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
JP6466924B2 (ja) | 2013-10-04 | 2019-02-06 | インフィニティー ファーマシューティカルズ, インコーポレイテッド | 複素環式化合物及びその使用 |
US20160244452A1 (en) | 2013-10-21 | 2016-08-25 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EP3087080B1 (en) | 2013-12-24 | 2018-11-28 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
US9775844B2 (en) | 2014-03-19 | 2017-10-03 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
US20150320754A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
WO2015168079A1 (en) | 2014-04-29 | 2015-11-05 | Infinity Pharmaceuticals, Inc. | Pyrimidine or pyridine derivatives useful as pi3k inhibitors |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
KR102269481B1 (ko) * | 2014-10-17 | 2021-06-28 | 삼성전자주식회사 | 디바이스 간에 화면 공유 방법 및 이를 이용하는 디바이스 |
EP3294298A4 (en) * | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
JP6796638B2 (ja) | 2015-06-04 | 2020-12-09 | ペレファーム, インク.Pellepharm, Inc. | ヘッジホッグ阻害性化合物の送達のための局所的製剤及びその使用 |
WO2017004411A1 (en) | 2015-07-01 | 2017-01-05 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses and uses thereof |
US20170231968A1 (en) | 2016-02-11 | 2017-08-17 | PellePharm, Inc. | Method for relief of and treatment of pruritus |
US10919914B2 (en) | 2016-06-08 | 2021-02-16 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
SG11201811237WA (en) | 2016-06-24 | 2019-01-30 | Infinity Pharmaceuticals Inc | Combination therapies |
CN112755042A (zh) * | 2019-11-06 | 2021-05-07 | 绍兴维帆生物技术有限公司 | 一种抗肿瘤药物的联合使用治疗白血病的方法 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2851054B2 (ja) | 1989-03-15 | 1999-01-27 | サントリー株式会社 | ベンズオキセピン誘導体 |
CA2179029C (en) | 1993-12-30 | 2009-02-24 | Philip W. Ingham | Vertebrate embryonic pattern-inducing hedgehog-like proteins |
US6281332B1 (en) | 1994-12-02 | 2001-08-28 | The Johns Hopkins University School Of Medicine | Hedgehog-derived polypeptides |
US7709454B2 (en) * | 1997-06-20 | 2010-05-04 | New York University | Methods and compositions for inhibiting tumorigenesis |
US6238876B1 (en) * | 1997-06-20 | 2001-05-29 | New York University | Methods and materials for the diagnosis and treatment of sporadic basal cell carcinoma |
US6867216B1 (en) * | 1998-04-09 | 2005-03-15 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signal pathways, compositions and uses related thereto |
US6432970B2 (en) * | 1998-04-09 | 2002-08-13 | Johns Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
US7291626B1 (en) * | 1998-04-09 | 2007-11-06 | John Hopkins University School Of Medicine | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto |
AU755943B2 (en) | 1998-08-13 | 2003-01-02 | University Of Southern California | Methods to increase blood flow to ischemic tissue |
US6291516B1 (en) | 1999-01-13 | 2001-09-18 | Curis, Inc. | Regulators of the hedgehog pathway, compositions and uses related thereto |
EP1728797A3 (en) * | 1999-10-13 | 2011-03-02 | Johns Hopkins University School of Medicine | Regulators of the hedgehog pathway, compositions and uses related thereto |
IL133809A0 (en) * | 1999-12-30 | 2001-04-30 | Yeda Res & Dev | Steroidal alkaloids and pharmaceutical compositions comprising them |
SE517003C2 (sv) * | 2000-09-05 | 2002-04-02 | Bofors Defence Ab | Sätt att öka skottvidden vid fenförsedda artelleriprojektiler samt sådan projektil |
US7708998B2 (en) * | 2000-10-13 | 2010-05-04 | Curis, Inc. | Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
US20040060568A1 (en) | 2000-10-13 | 2004-04-01 | Henryk Dudek | Hedgehog antagonists, methods and uses related thereto |
EP1401469A2 (en) * | 2001-04-09 | 2004-03-31 | Lorantis Limited | Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
WO2002078703A1 (en) * | 2001-07-02 | 2002-10-10 | Sinan Tas | Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
CA2452152A1 (en) | 2001-07-02 | 2002-10-10 | Sinan Tas | Use of cyclopamine in the treatment of psoriasis |
JP2003192919A (ja) | 2001-10-17 | 2003-07-09 | Asahi Denka Kogyo Kk | 難燃性合成樹脂組成物 |
EP1490031A1 (en) | 2002-03-07 | 2004-12-29 | Vectura Limited | Fast melt multiparticulate formulations for oral delivery |
GB0221539D0 (en) | 2002-09-17 | 2002-10-23 | Medical Res Council | Methods of treatment |
WO2005013800A2 (en) | 2003-07-15 | 2005-02-17 | The Johns Hopkins University | Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity |
US20080095761A1 (en) * | 2003-10-01 | 2008-04-24 | The Johns Hopkins University | Hedgehog Signaling in Prostate Regeneration Neoplasia and Metastasis |
US20070231828A1 (en) * | 2003-10-01 | 2007-10-04 | Johns Hopkins University | Methods of predicting behavior of cancers |
US20080057071A1 (en) * | 2003-10-20 | 2008-03-06 | Watkins David N | Use Of Hedgehog Pathway Inhibitors In Small-Cell Lung Cancer |
BRPI0514444A (pt) * | 2004-08-27 | 2008-06-10 | Infinity Pharmaceuticals Inc | análogos de ciclopamina e métodos de uso destes |
US20070281040A1 (en) * | 2004-09-30 | 2007-12-06 | The University Of Chicago | Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents |
US20090208579A1 (en) | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
WO2008121102A2 (en) * | 2006-02-21 | 2008-10-09 | The Regents Of The University Of Michigan | Hedgehog signaling pathway antagonist cancer treatment |
WO2007123511A2 (en) | 2006-03-24 | 2007-11-01 | Infinity Pharmaceuticals, Inc. | Dosing regimens for the treatment of cancer |
US20100048944A1 (en) | 2006-07-19 | 2010-02-25 | Farhad Parhami | Interactions of hedgehog and liver x receptor signaling pathways |
TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明(cyclopamine)類似物類 |
WO2008089123A2 (en) | 2007-01-12 | 2008-07-24 | Infinity Discovery, Inc. | Methods for analysis of hedgehog pathway inhibitors |
MX2009009429A (es) | 2007-03-07 | 2010-07-05 | Infinity Discovery Inc | Analogos de ciclopamina lactama y metodos de uso de los mismos. |
BRPI0808663A2 (pt) * | 2007-03-07 | 2014-08-26 | Infinity Discovery Inc | Análogos de cicloamina heterocíclicos e métodos de uso dos mesmos |
US7867492B2 (en) | 2007-10-12 | 2011-01-11 | The John Hopkins University | Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies |
ES2610130T3 (es) * | 2007-12-27 | 2017-04-26 | Infinity Pharmaceuticals, Inc. | Métodos para reducción estereoselectiva |
WO2009126840A1 (en) | 2008-04-11 | 2009-10-15 | Galaxy Biotech, Llc | Combination of hgf inhibitor and hedgehog inhibitor to treat cancer |
CL2009001479A1 (es) | 2008-07-02 | 2010-01-04 | Infinity Pharmaceuticals Inc | Metodo para aislar un alcaloide del veratrum desglicosilado que comprende proporcionar un material de planta veratrum, poner en contacto con una solucion acuosa y extraer el material de la planta veratrum con un solvente para proporcionar un extracto que comprende dicho alcaloide. |
CA2636807A1 (en) | 2008-07-04 | 2010-01-04 | Steven Splinter | Methods for obtaining cyclopamine |
ES2567134T3 (es) * | 2009-08-05 | 2016-04-20 | Infinity Pharmaceuticals, Inc. | Transaminación enzimática de análogos de ciclopamina |
-
2008
- 2008-03-07 MX MX2009009429A patent/MX2009009429A/es active IP Right Grant
- 2008-03-07 EP EP08731680.8A patent/EP2134719B1/en active Active
- 2008-03-07 RU RU2009137012/04A patent/RU2009137012A/ru not_active Application Discontinuation
- 2008-03-07 CN CN200880012481.0A patent/CN101675054B/zh not_active Expired - Fee Related
- 2008-03-07 WO PCT/US2008/056229 patent/WO2008109829A1/en active Application Filing
- 2008-03-07 JP JP2009552909A patent/JP2010520310A/ja not_active Ceased
- 2008-03-07 CN CN201410167875.0A patent/CN104193797A/zh active Pending
- 2008-03-07 NZ NZ579356A patent/NZ579356A/en not_active IP Right Cessation
- 2008-03-07 AU AU2008222655A patent/AU2008222655B2/en not_active Ceased
- 2008-03-07 CA CA002679845A patent/CA2679845A1/en not_active Abandoned
- 2008-03-07 US US12/044,878 patent/US7964590B2/en not_active Expired - Fee Related
- 2008-03-07 KR KR1020097020902A patent/KR20090117956A/ko not_active Application Discontinuation
- 2008-03-07 BR BRPI0808444A patent/BRPI0808444A2/pt not_active IP Right Cessation
-
2009
- 2009-09-02 ZA ZA2009/06083A patent/ZA200906083B/en unknown
- 2009-09-03 IL IL200746A patent/IL200746A0/en unknown
-
2010
- 2010-06-17 HK HK10106043.2A patent/HK1139930A1/xx not_active IP Right Cessation
-
2011
- 2011-05-06 US US13/102,395 patent/US8293760B2/en not_active Expired - Fee Related
- 2011-09-30 US US13/250,080 patent/US8431566B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2008109829A1 (en) | 2008-09-12 |
AU2008222655A1 (en) | 2008-09-12 |
ZA200906083B (en) | 2011-03-30 |
EP2134719B1 (en) | 2013-07-17 |
EP2134719A1 (en) | 2009-12-23 |
IL200746A0 (en) | 2010-05-17 |
RU2009137012A (ru) | 2011-04-20 |
US20080287420A1 (en) | 2008-11-20 |
HK1139930A1 (en) | 2010-09-30 |
US20120083484A1 (en) | 2012-04-05 |
US8293760B2 (en) | 2012-10-23 |
JP2010520310A (ja) | 2010-06-10 |
CN104193797A (zh) | 2014-12-10 |
AU2008222655B2 (en) | 2014-03-27 |
NZ579356A (en) | 2012-04-27 |
US20120015934A1 (en) | 2012-01-19 |
KR20090117956A (ko) | 2009-11-16 |
CN101675054B (zh) | 2014-05-14 |
US7964590B2 (en) | 2011-06-21 |
CA2679845A1 (en) | 2008-09-12 |
EP2134719A4 (en) | 2011-08-17 |
US8431566B2 (en) | 2013-04-30 |
BRPI0808444A2 (pt) | 2017-06-06 |
CN101675054A (zh) | 2010-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009009429A (es) | Analogos de ciclopamina lactama y metodos de uso de los mismos. | |
MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
MX2010000098A (es) | Derivados de guanina policiclicos y sus metodos de uso. | |
MY158257A (en) | Forms of rifaximin and uses thereof | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
PL2134704T3 (pl) | Związki i kompozycje pełniące rolę modulatorów aktywności GPR119 | |
UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
UA102065C2 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof | |
WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
MX2014015004A (es) | Inhibidores de bromodominio de benzo [c] isoxazoloazepina y sus usos. | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
IL177483A0 (en) | Means for transdermal administration of nicotine | |
SG178999A1 (en) | Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | |
MX2012000396A (es) | Metodos y composiciones para uso en tartamientos celulares. | |
IN2012DN02471A (es) | ||
TW200716091A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
UA107334C2 (ru) | Производные аминоэфиров алкалоидов и их лекарственные композиции | |
IL205696A0 (en) | Heterocyclic derivatives, compositions comprising the same and uses thereof | |
TW200942530A (en) | Pyridine compounds | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
ZA201000581B (en) | 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |